PAA 0.00% 20.0¢ pharmaust limited

Ann: Phase II Dog Lymphoma Trial Confirms MPL Clinical Benefit, page-24

  1. 16,819 Posts.
    lightbulb Created with Sketch. 356
    I know the slow and steady decline/accumulation phase in this stock has been hard for people to accept but it's going to pay off very strongly in the longer term because the company is now poised on many fronts to release steady and reliable news
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
0.000(0.00%)
Mkt cap ! $89.00M
Open High Low Value Volume
19.5¢ 20.0¢ 19.5¢ $101.0K 508.8K

Buyers (Bids)

No. Vol. Price($)
7 420397 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 8821 1
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.